CURIOSITYSTREAM INC (CURI) Fundamental Analysis & Valuation

NASDAQ:CURI • US23130Q1076

Current stock price

2.93 USD
-0.03 (-1.01%)
Last:

This CURI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CURI Profitability Analysis

1.1 Basic Checks

  • In the past year CURI has reported negative net income.
  • In the past year CURI had a positive cash flow from operations.
  • CURI had negative earnings in each of the past 5 years.
  • CURI had negative operating cash flow in 4 of the past 5 years.
CURI Yearly Net Income VS EBIT VS OCF VS FCFCURI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • CURI has a worse Return On Assets (-7.30%) than 63.29% of its industry peers.
  • With a Return On Equity value of -11.56%, CURI perfoms like the industry average, outperforming 46.84% of the companies in the same industry.
Industry RankSector Rank
ROA -7.3%
ROE -11.56%
ROIC N/A
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
CURI Yearly ROA, ROE, ROICCURI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • CURI has a better Gross Margin (54.50%) than 62.03% of its industry peers.
  • CURI's Gross Margin has been stable in the last couple of years.
  • CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
CURI Yearly Profit, Operating, Gross MarginsCURI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CURI Health Analysis

2.1 Basic Checks

  • CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CURI Yearly Shares OutstandingCURI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CURI Yearly Total Debt VS Total AssetsCURI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • CURI has an Altman-Z score of -1.53. This is a bad value and indicates that CURI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.53, CURI is not doing good in the industry: 70.89% of the companies in the same industry are doing better.
  • There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -1.53
ROIC/WACCN/A
WACC9.38%
CURI Yearly LT Debt VS Equity VS FCFCURI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that CURI should not have too much problems paying its short term obligations.
  • CURI has a better Current ratio (1.62) than 68.35% of its industry peers.
  • CURI has a Quick Ratio of 1.62. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.62, CURI is doing good in the industry, outperforming 70.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
CURI Yearly Current Assets VS Current LiabilitesCURI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CURI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.17% over the past year.
EPS 1Y (TTM)54.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%35.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 76.66% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CURI will show a small growth in Revenue. The Revenue will grow by 7.31% on average per year.
EPS Next Y118.55%
EPS Next 2Y79.04%
EPS Next 3Y128.45%
EPS Next 5Y76.66%
Revenue Next Year10.9%
Revenue Next 2Y13.08%
Revenue Next 3Y11.57%
Revenue Next 5Y7.31%

3.3 Evolution

CURI Yearly Revenue VS EstimatesCURI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
CURI Yearly EPS VS EstimatesCURI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. CURI Valuation Analysis

4.1 Price/Earnings Ratio

  • CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 143.63, which means the current valuation is very expensive for CURI.
  • CURI's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CURI to the average of the S&P500 Index (22.81), we can say CURI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 143.63
CURI Price Earnings VS Forward Price EarningsCURI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CURI is valued a bit cheaper than the industry average as 68.35% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CURI is valued cheaply inside the industry as 89.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.34
EV/EBITDA 16.79
CURI Per share dataCURI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CURI's earnings are expected to grow with 128.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.04%
EPS Next 3Y128.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CURI Dividend Analysis

5.1 Amount

  • CURI has a Yearly Dividend Yield of 10.36%, which is a nice return.
  • In the last 3 months the price of CURI has falen by -21.28%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • CURI's Dividend Yield is rather good when compared to the industry average which is at 6.06. CURI pays more dividend than 97.47% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CURI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.36%

5.2 History

  • CURI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CURI Yearly Dividends per shareCURI Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.1 0.2 0.3

5.3 Sustainability

  • The earnings of CURI are negative and hence is the payout ratio. CURI will probably not be able to sustain this dividend level.
DP-342.83%
EPS Next 2Y79.04%
EPS Next 3Y128.45%
CURI Yearly Income VS Free CF VS DividendCURI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

More info and screens

Find the best dividend stocksShow peers with best dividend

CURI Fundamentals: All Metrics, Ratios and Statistics

CURIOSITYSTREAM INC

NASDAQ:CURI (4/1/2026, 1:35:48 PM)

2.93

-0.03 (-1.01%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-11
Earnings (Next)05-04
Inst Owners34.74%
Inst Owner Change1.4%
Ins Owners8.18%
Ins Owner Change2.62%
Market Cap172.78M
Revenue(TTM)N/A
Net Income(TTM)-5.45M
Analysts86
Price Target6.5 (121.84%)
Short Float %6.84%
Short Ratio6.53
Dividend
Industry RankSector Rank
Dividend Yield 10.36%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-342.83%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-06
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.44%
Min Revenue beat(2)9.49%
Max Revenue beat(2)13.4%
Revenue beat(4)3
Avg Revenue beat(4)6.66%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)13.4%
Revenue beat(8)3
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)-2.28%
Revenue beat(16)8
Avg Revenue beat(16)-1.46%
PT rev (1m)-1.92%
PT rev (3m)-1.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20%
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 143.63
P/S 2.59
P/FCF 14.34
P/OCF 14.25
P/B 3.66
P/tB 9.04
EV/EBITDA 16.79
EPS(TTM)-0.11
EYN/A
EPS(NY)0.02
Fwd EY0.7%
FCF(TTM)0.2
FCFY6.97%
OCF(TTM)0.21
OCFY7.02%
SpS1.13
BVpS0.8
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.3%
ROE -11.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.5%
FCFM 18.09%
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score7
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0.5%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion 152.89%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z -1.53
F-Score7
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)0.12%
Cap/Depr(5y)1.04%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y118.55%
EPS Next 2Y79.04%
EPS Next 3Y128.45%
EPS Next 5Y76.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%35.82%
Revenue Next Year10.9%
Revenue Next 2Y13.08%
Revenue Next 3Y11.57%
Revenue Next 5Y7.31%
EBIT growth 1Y43.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.9%
EBIT Next 3Y51.92%
EBIT Next 5Y26.01%
FCF growth 1Y153.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y154.1%
OCF growth 3YN/A
OCF growth 5YN/A

CURIOSITYSTREAM INC / CURI Fundamental Analysis FAQ

What is the fundamental rating for CURI stock?

ChartMill assigns a fundamental rating of 3 / 10 to CURI.


Can you provide the valuation status for CURIOSITYSTREAM INC?

ChartMill assigns a valuation rating of 4 / 10 to CURIOSITYSTREAM INC (CURI). This can be considered as Fairly Valued.


What is the profitability of CURI stock?

CURIOSITYSTREAM INC (CURI) has a profitability rating of 1 / 10.


What is the financial health of CURIOSITYSTREAM INC (CURI) stock?

The financial health rating of CURIOSITYSTREAM INC (CURI) is 5 / 10.


Is the dividend of CURIOSITYSTREAM INC sustainable?

The dividend rating of CURIOSITYSTREAM INC (CURI) is 4 / 10 and the dividend payout ratio is -342.83%.